Norgine
Norgine is a leading European specialist pharmaceutical company with a direct commercial presence in all major European markets.
The company specializes in gastroenterology, hepatology, cancer and supportive care. Its annual sales are in excess of $400 million.
In 2012, the group established a complementary business, Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the USA.
Latest Norgine News & Features
16 September 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze